Creation of novel Protein Transduction Domain (PTD) mutants by a phage display-based high-throughput screening system

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 8, 2006, Pages 1570-1574

  Mukai, Yohei ^a,b   Sugita, Toshiki ^a,b   Yamato, Tomoko ^a,b   Yamanada, Natsue ^a,b   Shibata, Hiroko ^a,b   Imai, Sunao ^a,b   Abe, Yasuhiro ^a,b   Nagano, Kazuya ^a,b   Nomura, Tetsuya ^a,b   Tsutsumi, Yasuo ^a,b   Kamada, Haruhiko ^a   Nakagawa, Shinsaku ^b   Tsunoda, Shin Ichi ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

High throughput screening; HIV 1 Tat; Intracellular drug delivery; Phage display system; Protein transduction domain

Indexed keywords

HYBRID PROTEIN; MUTANT PROTEIN; NANOCRYSTAL; PROLINE; PROTEIN SYNTHESIS INHIBITOR; PROTEIN TRANSDUCTION DOMAIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY;

BACTERIOPHAGES; BASE SEQUENCE; DNA PRIMERS; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MUTATION; PROTEINS; TRANSDUCTION, GENETIC;

EID: 33746758914     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1570     Document Type: Article

References (28)

1. Wadia J. S., Dowdy S. F., Curr. Protein Pept. Sci., 4, 97-104 (2003).
2. Wadia J. S., Dowdy S. F., Curr. Opin. Biotechnol., 13, 52-56 (2002).
3. Prochiantz A., Curr. Opin. Cell. Biol., 12, 400-406 (2000).
4. Li Y., Rosal R. V., Brandt-Rauf P. W., Fine R. L., Biochem. Biophys. Res. Commun., 298, 439-449 (2002).
5. Cao G., Pei W., Ge H., Liang Q., Luo Y., Sharp F. R., Lu A., Ran R., Graham S. H., Chen J., J. Neurosci., 22, 5423-5431 (2002).
6. Shibagaki N., Udey M. C., Eur. J. Immunol., 33, 850-860 (2003).
7. Tanaka Y., Dowdy S. F., Linehan D. C., Eberlein T. J., Goedegebuure P. S., J. Immunol., 170, 1291-1298 (2003).
8. Kim T. G., Befus N., Langridge W. H., Vaccine, 22, 431-438 (2004).
9. Tasciotti E., Zoppe M., Giacca M., Cancer Gene Ther., 10, 64-74 (2003).
10. Astriab-Fisher A., Sergueev D. S., Fisher M., Shaw B. R., Juliano R. L., Biochem. Pharmacol., 60, 83-90 (2000).
11. Lewin M., Carlesso N., Tung C. H., Tang X. W., Cory D., Scadden D. T., Nat Biotechnol., 18, 410-414 (2000).
12. Torchilin V. P., Rammohan R., Weissig V., Levchenko T. S., Proc. Natl. Acad. Sci. U.S.A., 98, 8786-8791 (2001).
13. Torchilin V. P., Levchenko T. S., Curr. Protein Pept. Sci., 4, 133-140 (2003).
14. Ho A., Schwarze S. R., Mermelstein S. J., Waksman G., Dowdy S. F., Cancer Res., 61, 474-477 (2001).
15. Morris M. C., Depollier J., Mery J., Heitz F., Nat. Biotechnol., 19, 1173-1176 (2001).
16. Yamamoto Y., Tsutsumi Y., Yoshioka Y., Nishibata T., Kobayashi K., Okamoto T., Mukai Y., Shimizu T., Nakagawa S., Nagata S., Mayumi T., Nat. Biotechnol., 21, 546-552 (2003).
17. Pasqualini R., Ruoslahti E., Nature (Lomdon), 380, 364-366 (1996).
18. Pasqualini R., Ruoslahti E., Mol. Psychiatry, 1, 421-422 (1996).
19. Smith G. P., Science, 228, 1315-1317 (1985).
20. Rossenu S., Dewitte D., Vandekerckhove J., Ampe C., J. Protein Chem., 16, 499-503 (1997).
21. Kreitman R. J., Curr. Opin. Immunol., 11, 570-578 (1999).
22. Chaudhary V. K., FitzGerald D. J., Adhya S., Pastan I., Proc. Natl. Acad. Sci. U.S.A., 84, 4538-4542 (1987).
23. Kreitman R. J., Wilson W. H., Bergeron K., Raggio M., Stetler-Stevenson M., FitzGerald D. J., Pastan I., N. Engl. J. Med., 345, 241-247 (2001).
24. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y., J. Biol. Chem., 276, 5836-5840 (2001).
25. Jones S. W., Christison R., Bundell K., Voyce C. J., Brockbank S. M., Newham P., Lindsay M. A., Br. J. Pharmacol., 145, 1093-1102 (2005).
26. Wadia J. S., Stan R. V., Dowdy S. F., Nat. Med., 10, 310-315 (2004).
27. Kaplan I. M., Wadia J. S., Dowdy S. F., J. Control. Release, 102, 247-253 (2005).
28. Michiue H., Tomizawa K., Wei F. Y., Matsushita M., Lu Y. F., Ichikawa T., Tamiya T., Date I., J. Biol. Chem., 280, 8285-8289 (2005).